IRIS Accounts Production v26.2.0.496 03263789 Board of Directors 1.1.25 31.12.25 31.12.25 false true false false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh032637892024-12-31032637892025-12-31032637892025-01-012025-12-31032637892023-12-31032637892024-01-012024-12-31032637892024-12-3103263789ns15:EnglandWales2025-01-012025-12-3103263789ns14:PoundSterling2025-01-012025-12-3103263789ns10:Director12025-01-012025-12-3103263789ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3103263789ns10:SmallEntities2025-01-012025-12-3103263789ns10:AuditExempt-NoAccountantsReport2025-01-012025-12-3103263789ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3103263789ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3103263789ns10:FullAccounts2025-01-012025-12-310326378912025-01-012025-12-3103263789ns10:Director22025-01-012025-12-3103263789ns10:Director32025-01-012025-12-3103263789ns10:CompanySecretary12025-01-012025-12-3103263789ns10:RegisteredOffice2025-01-012025-12-3103263789ns5:CurrentFinancialInstruments2025-12-3103263789ns5:CurrentFinancialInstruments2024-12-3103263789ns5:Non-currentFinancialInstruments2025-12-3103263789ns5:Non-currentFinancialInstruments2024-12-3103263789ns5:ShareCapital2025-12-3103263789ns5:ShareCapital2024-12-3103263789ns5:FurtherSpecificReserve3ComponentTotalEquity2025-12-3103263789ns5:FurtherSpecificReserve3ComponentTotalEquity2024-12-3103263789ns5:RetainedEarningsAccumulatedLosses2025-12-3103263789ns5:RetainedEarningsAccumulatedLosses2024-12-3103263789ns5:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3103263789ns5:PatentsTrademarksLicencesConcessionsSimilar2025-01-012025-12-3103263789ns5:PlantMachinery2025-01-012025-12-3103263789ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3103263789ns5:PatentsTrademarksLicencesConcessionsSimilar2025-12-3103263789ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3103263789ns5:PlantMachinery2024-12-3103263789ns5:PlantMachinery2025-12-3103263789ns5:PlantMachinery2024-12-3103263789ns5:CostValuation2024-12-3103263789ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3103263789ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3103263789ns5:AfterOneYearns5:Non-currentFinancialInstruments2025-12-3103263789ns5:AfterOneYearns5:Non-currentFinancialInstruments2024-12-3103263789ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-12-3103263789ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-12-3103263789ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-12-3103263789ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-12-3103263789ns5:MoreThanFiveYearsns5:Non-currentFinancialInstruments2025-12-3103263789ns5:MoreThanFiveYearsns5:Non-currentFinancialInstruments2024-12-3103263789ns5:FurtherSpecificReserve3ComponentTotalEquity2024-12-31
REGISTERED NUMBER: 03263789 (England and Wales)















Financial Statements for the Year Ended 31st December 2025

for

Medichem Properties Ltd

Medichem Properties Ltd (Registered number: 03263789)

Contents of the Financial Statements
for the Year Ended 31st December 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Medichem Properties Ltd

Company Information
for the Year Ended 31st December 2025







DIRECTORS: T D Allsworth
C A Morris
R Lee





SECRETARY: C A Morris





REGISTERED OFFICE: Unit 3 Stalham Business Park
Rushenden Road
Queensborough
Kent
ME11 5HE





REGISTERED NUMBER: 03263789 (England and Wales)





ACCOUNTANTS: Beak Kemmenoe
Chartered Accountants
1-3 Manor Road
Chatham
Kent
ME4 6AE

Medichem Properties Ltd (Registered number: 03263789)

Balance Sheet
31st December 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 5 5,264 7,177
Tangible assets 6 72,511 88,423
Investments 7 68,508 68,508
Investment property 8 37,966,824 38,228,874
38,113,107 38,392,982

CURRENT ASSETS
Debtors 9 3,994,572 2,901,408
Investments 10 6,694,876 4,881,877
Cash at bank 7,082,752 7,843,114
17,772,200 15,626,399
CREDITORS
Amounts falling due within one year 11 1,454,800 874,169
NET CURRENT ASSETS 16,317,400 14,752,230
TOTAL ASSETS LESS CURRENT
LIABILITIES

54,430,507

53,145,212

CREDITORS
Amounts falling due after more than one
year

12

(41,206,922

)

(40,662,520

)

PROVISIONS FOR LIABILITIES (1,558,948 ) (1,594,031 )
NET ASSETS 11,664,637 10,888,661

CAPITAL AND RESERVES
Called up share capital 2 2
Fair value reserve 14 5,153,247 5,392,819
Retained earnings 6,511,388 5,495,840
11,664,637 10,888,661

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Medichem Properties Ltd (Registered number: 03263789)

Balance Sheet - continued
31st December 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17th September 2026 and were signed on its behalf by:





T D Allsworth - Director


Medichem Properties Ltd (Registered number: 03263789)

Notes to the Financial Statements
for the Year Ended 31st December 2025


1. STATUTORY INFORMATION

Medichem Properties Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Preparation of consolidated financial statements
The Financial statements contain information about Medichem Properties Ltd as an individual company and do not contain consolidated financial information as the parent of a group. The company has taken the option under Section 398 of the Companies Act 2006 not to prepare consolidated financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Trademarks are being amortised evenly over their estimated useful life of seven years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on reducing balance and 10% on reducing balance

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Medichem Properties Ltd (Registered number: 03263789)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2025


3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 4 ) .

5. INTANGIBLE FIXED ASSETS
Trademarks
£   
COST
At 1st January 2025
and 31st December 2025 13,394
AMORTISATION
At 1st January 2025 6,217
Amortisation for year 1,913
At 31st December 2025 8,130
NET BOOK VALUE
At 31st December 2025 5,264
At 31st December 2024 7,177

Medichem Properties Ltd (Registered number: 03263789)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2025


6. TANGIBLE FIXED ASSETS
Plant and
machinery
£   
COST
At 1st January 2025
and 31st December 2025 334,548
DEPRECIATION
At 1st January 2025 246,125
Charge for year 15,912
At 31st December 2025 262,037
NET BOOK VALUE
At 31st December 2025 72,511
At 31st December 2024 88,423

7. FIXED ASSET INVESTMENTS
Share in
linked
undertaking
£   
COST
At 1st January 2025
and 31st December 2025 68,508
NET BOOK VALUE
At 31st December 2025 68,508
At 31st December 2024 68,508

8. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1st January 2025 38,228,874
Additions 717,950
Disposals (980,000 )
At 31st December 2025 37,966,824
NET BOOK VALUE
At 31st December 2025 37,966,824
At 31st December 2024 38,228,874

Medichem Properties Ltd (Registered number: 03263789)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2025


8. INVESTMENT PROPERTY - continued

Fair value at 31st December 2025 is represented by:
£   
Valuation in 2017 9,717,030
Valuation in 2018 10,530,000
Valuation in 2020 4,751,950
Valuation in 2020 349,261
Valuation in 2021 21,268
Valuation in 2022 1,355,132
Valuation in 2023 6,187,916
Valuation in 2024 5,316,317
Valuation in 2025 (262,050 )
37,966,824

9. DEBTORS
2025 2024
£    £   
Amounts falling due within one year:
Other debtors and prepayments 1,888,844 803,009

Amounts falling due after more than one year:
Other debtors 2,105,728 2,098,399

Aggregate amounts 3,994,572 2,901,408

10. CURRENT ASSET INVESTMENTS
2025 2024
£    £   
Unlisted investments 6,694,876 4,881,877

11. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 119,905 130,792
Corporation Tax 40,191 -
Other creditors and accruals 1,294,704 743,377
1,454,800 874,169

Medichem Properties Ltd (Registered number: 03263789)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2025


12. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans - 1-2 years 121,351 133,415
Bank loans - 2-5 years 364,126 408,726
Bank loans over 5 years 18,327,689 17,312,832
Directors' loan accounts 22,393,756 22,807,547
41,206,922 40,662,520

Amounts falling due in more than five years:

Repayable by instalments
Bank loans over 5 years 18,327,689 17,312,832

13. SECURED DEBTS

The following secured debts are included within creditors:

2025 2024
£    £   
Bank loans 18,933,071 17,599,661

Secured on the assets concerned.

14. RESERVES
Fair
value
reserve
£   
At 1st January 2025 5,392,819
Revaluation of fixed assets (239,572 )

At 31st December 2025 5,153,247